| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |